Table 4

Univariate correlations with left ventricular 2D speckle-tracking global longitudinal strain

Patients receiving clozapine (n=100)All patients with schizophrenia (clozapine and non-clozapine=121)
Correlation coefficientp ValueCorrelation coefficientp Value
Patient receiving clozapine0.35<0.001*
Heart rate0.230.03*0.36<0.001*
HDL-C level−0.35<0.001*−0.220.02*
Triglyceride level0.200.04*0.200.03*
Body mass index0.290.02*0.210.03*
Diabetes0.190.060.190.04*
HsCRP0.240.02*0.180.05
Smoking0.220.02*0.180.06
Neutrophil count0.250.01*0.170.06
Hypercholesterolaemia0.160.120.150.11
Eosinophil count−0.030.75−0.150.11
NT-proBNP−0.210.03*−0.150.17
HbA1c0.180.080.140.19
HsTropT0.010.890.070.45
Age0.010.900.070.47
  • Pearson, Spearman or point-biserial correlation analysis performed based on variable type.

  • 2D, two-dimensional; HbA1c, glycosylated haemoglobin; HDL-C, high-density lipoprotein cholesterol; HsCRP, high-sensitivity C reactive protein; HsTropT, high-sensitivity troponin T; NT-proBNP, N-terminal pro-B-type natriuretic peptide.